The Analysis of BIOS Capital Management, LP's Holdings & P&L

Currently, BIOS Capital Management, LP holds 6 types of securities in its portfolio with a total value $52.9M. In the most recent quarter, they have increased their positions in RNTX (+291.6K shares, valued at $379.1K); decreased their positions in LTRN (-145.1K shares, valued at $198.7K), INAB (-85.6K shares, valued at $126.7K).

1M P&L

-5.1M-8.82%

3M P&L

-12.4M-19.05%

HY P&L

-33.0M-38.45%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology82.6M

100.0%

Top Industries by Stock Count

1Biotechnology6 stocks

100.0%

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

ACTU ACTUATE THERAPEUTICS INC10.0M shares0.00%2026-03-312026-05-13

IRD OPUS GENETICS INC3.7M shares0.00%2026-03-312026-05-13

CGTX COGNITION THERAPEUTICS INC6.0M shares0.00%2026-03-312026-05-13

RNTX REIN THERAPEUTICS INC2.0M shares17.25%2026-03-312026-05-13

LTRN LANTERN PHARMA INC864.4K shares-14.37%2026-03-312026-05-13

INAB IN8BIO INC167.8K shares-33.78%2026-03-312026-05-13

ACTU

ACTUATE THERAPEUTICS INC

0.00%

Shares10.0M

Event2026-03-31

Filed2026-05-13

IRD

OPUS GENETICS INC

0.00%

Shares3.7M

Event2026-03-31

Filed2026-05-13

CGTX

COGNITION THERAPEUTICS INC

0.00%

Shares6.0M

Event2026-03-31

Filed2026-05-13

RNTX

REIN THERAPEUTICS INC

17.25%

Shares2.0M

Event2026-03-31

Filed2026-05-13

LTRN

LANTERN PHARMA INC

-14.37%

Shares864.4K

Event2026-03-31

Filed2026-05-13

INAB

IN8BIO INC

-33.78%

Shares167.8K

Event2026-03-31

Filed2026-05-13

Call Option Holdings

No call option holdings data available

Put Option Holdings

No put option holdings data available